These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 27842171)

  • 21. Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel Survey.
    Salami JA; Valero-Elizondo J; Ogunmoroti O; Spatz ES; Rana JS; Virani SS; Blankstein R; Younus A; Arrieta A; Blaha MJ; Veledar E; Nasir K
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28600400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines.
    Matyori A; Brown CP; Ali A; Sherbeny F
    Saudi Pharm J; 2023 Jun; 31(6):795-800. PubMed ID: 37228328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin Use in Older Adults with Stable Atherosclerotic Cardiovascular Disease.
    Spencer-Bonilla G; Chung S; Sarraju A; Heidenreich P; Palaniappan L; Rodriguez F
    J Am Geriatr Soc; 2021 Apr; 69(4):979-985. PubMed ID: 33410499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of Potential Savings Through Therapeutic Substitution.
    Johansen ME; Richardson C
    JAMA Intern Med; 2016 Jun; 176(6):769-75. PubMed ID: 27159226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National Trends in Cessation Counseling, Prescription Medication Use, and Associated Costs Among US Adult Cigarette Smokers.
    Tibuakuu M; Okunrintemi V; Jirru E; Echouffo Tcheugui JB; Orimoloye OA; Mehta PK; DeFilippis AP; Blaha MJ; Michos ED
    JAMA Netw Open; 2019 May; 2(5):e194585. PubMed ID: 31125108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020.
    Jacobs JA; Addo DK; Zheutlin AR; Derington CG; Essien UR; Navar AM; Hernandez I; Lloyd-Jones DM; King JB; Rao S; Herrick JS; Bress AP; Pandey A
    JAMA Cardiol; 2023 May; 8(5):443-452. PubMed ID: 36947031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
    Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
    JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin Use in Older Adults for Primary Cardiovascular Disease Prevention Across a Spectrum of Cardiovascular Risk.
    Sarraju A; Spencer-Bonilla G; Chung S; Gomez S; Li J; Heidenreich P; Palaniappan L; Rodriguez F
    J Gen Intern Med; 2022 Aug; 37(11):2642-2649. PubMed ID: 34505981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES study.
    Anderson JL; Knowlton KU; May HT; Bair TL; Armstrong SO; Lappé DL; Muhlestein JB
    J Clin Lipidol; 2018; 12(4):1008-1018.e1. PubMed ID: 29703626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.
    Sicras-Mainar A; Sánchez-Álvarez L; Navarro-Artieda R; Darbà J
    Lipids Health Dis; 2018 Dec; 17(1):277. PubMed ID: 30522491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in direct health care costs among US adults with atherosclerotic cardiovascular disease with and without diabetes.
    Shah CH; Fonarow GC; Echouffo-Tcheugui JB
    Cardiovasc Diabetol; 2024 Jul; 23(1):238. PubMed ID: 38978114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013.
    Okunrintemi V; Spatz ES; Di Capua P; Salami JA; Valero-Elizondo J; Warraich H; Virani SS; Blaha MJ; Blankstein R; Butt AA; Borden WB; Dharmarajan K; Ting H; Krumholz HM; Nasir K
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease.
    Mahtta D; Ramsey DJ; Al Rifai M; Nasir K; Samad Z; Aguilar D; Jneid H; Ballantyne CM; Petersen LA; Virani SS
    JAMA Netw Open; 2020 Aug; 3(8):e2011051. PubMed ID: 32816031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in Out-of-Pocket Costs for Naloxone by Drug Brand and Payer in the US, 2010-2018.
    Peet ED; Powell D; Pacula RL
    JAMA Health Forum; 2022 Aug; 3(8):e222663. PubMed ID: 36200636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription of statins: cost implications of evidence-based treatment applied to a health authority population.
    Bradshaw N; Walker R
    J Clin Pharm Ther; 1997; 22(5-6):379-89. PubMed ID: 19160723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
    Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
    Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in Healthcare Expenditures among Individuals with Arthritis in the United States from 2008 to 2014.
    Raval AD; Vyas A
    J Rheumatol; 2018 May; 45(5):705-716. PubMed ID: 29335341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of China's Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease.
    Wang M; Liu J; Bellows BK; Qi Y; Sun J; Liu J; Moran AE; Zhao D
    Glob Heart; 2020 Jun; 15(1):43. PubMed ID: 32923337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis.
    Boettiger DC; Chattranukulchai P; Avihingsanon A; Chaiwarith R; Khusuwan S; Law MG; Ross J; Kiertiburanakul S
    PLoS One; 2021; 16(9):e0256926. PubMed ID: 34499685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.